StocksDeepDive
Snapshot · Russell 3000 · generated 2026-10-17 22:04 UTC

ANIP — ANI Pharmaceuticals, Inc.

UNDERVALUED (MOS +58.4%) · Quality 74/100

Price
72.29
Intrinsic value
173.6
Margin of safety
+58.4%
Implied growth (reverse DCF)
-0.3%
model assumes +14.0%
Value Score
51.1
Quality
74
Psychology
12.5
Discovery
11
price/volume attention only
Moat score
40
erosion: none

Value Score: top 4% of Russell 3000 · Quality: top 10%

Open the interactive Deep Dive for ANIP →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/ANIP - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is ANIP undervalued?

As of 2026-10-17, ANIP trades at 72.29 against a computed intrinsic value of 173.6 (+58.4% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is ANI Pharmaceuticals, Inc.'s Value Score?

ANI Pharmaceuticals, Inc.'s Value Score is 51.1 as of 2026-10-17 - it combines value, quality, crowd psychology and market attention into one number.